Foreign drug company Bayer AG, has pulled Trasylol from U.S. shelves. Trasylol has been used to reduce blood loss for patients undergoing by-pass surgery and avoid transfusions. The drug was pulled amid concerns that it may be linked to a higher risk of death than other drugs. So far, no advised against continued use of the drug because of the risk of kidney failure, and increased risk of heart attacks, heart failure and strokes.
Click here for the full article